Hunter R. Murdock - 16 Jun 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Signature
/s/ Hunter Murdock
Issuer symbol
AXSM
Transactions as of
16 Jun 2025
Net transactions value
-$1,603,875
Form type
4
Filing time
18 Jun 2025, 21:16:04 UTC
Previous filing
25 Feb 2025
Next filing
23 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Murdock Hunter R. General Counsel C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK /s/ Hunter Murdock 18 Jun 2025 0001934008

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Options Exercise $224,325 +7,500 $29.91 7,500 16 Jun 2025 Direct F1
transaction AXSM Common Stock Sale $768,150 -7,500 -100% $102.42 0 16 Jun 2025 Direct F1, F2, F3
transaction AXSM Common Stock Options Exercise $224,325 +7,500 $29.91 7,500 17 Jun 2025 Direct F1
transaction AXSM Common Stock Sale $751,950 -7,500 -100% $100.26 0 17 Jun 2025 Direct F1, F2, F4
transaction AXSM Common Stock Options Exercise $224,325 +7,500 $29.91 7,500 18 Jun 2025 Direct F1
transaction AXSM Common Stock Sale $756,750 -7,500 -100% $100.90 0 18 Jun 2025 Direct F1, F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -7,500 -14% $0.000000 44,883 16 Jun 2025 Common Stock 7,500 $29.91 Direct F1
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -7,500 -17% $0.000000 37,383 17 Jun 2025 Common Stock 7,500 $29.91 Direct F1
transaction AXSM Stock Option (Right to Buy) Options Exercise $0 -7,500 -20% $0.000000 29,883 18 Jun 2025 Common Stock 7,500 $29.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Such transaction was pursuant to a pre-approved 10b5-1 plan.
F2 Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
F3 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.01 and $104.09
F4 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.53.
F5 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.96.